Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
Citation: New England Journal of Medicine. 379(12):1107-1117, 2018 09 20.PMID: 30145941Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Anti-Obesity Agents/tu [Therapeutic Use] | *Benzazepines/tu [Therapeutic Use] | *Cardiovascular Diseases/co [Complications] | *Hypoglycemia/ci [Chemically Induced] | *Obesity/dt [Drug Therapy] | *Overweight/dt [Drug Therapy] | *Weight Loss/de [Drug Effects] | Aged | Anti-Obesity Agents/ae [Adverse Effects] | Aortic Valve Insufficiency/ci [Chemically Induced] | Benzazepines/ae [Adverse Effects] | Cardiovascular Diseases/ci [Chemically Induced] | Cardiovascular Diseases/ep [Epidemiology] | Diabetes Mellitus, Type 2/co [Complications] | Double-Blind Method | Female | Follow-Up Studies | Humans | Hypertension, Pulmonary/ci [Chemically Induced] | Male | Middle Aged | Obesity/co [Complications] | Overweight/co [Complications] | Risk FactorsYear: 2018ISSN:- 0028-4793
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 30145941 | Available | 30145941 |
English